133 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
of Health, and the Bill & Melinda Gates Foundation, and is being conducted by the HIV Vaccine Trials Network.
◦In December, Nature Medicine recognized
S-3ASR
VIR
Vir Biotechnology Inc
3 Nov 23
Automatic shelf registration
4:33pm
or more conditions precedent. In that case, such notice shall state the nature of such condition precedent. If we elect to redeem a portion
S-3ASR
EX-4.5
tak0y8c
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.6
9gg43fi5fwwsai69hu
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
9tfftwcp
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm